The time is now. Urge Congress to pass PASTEUR
Because of the thick, sticky mucus in their lungs, people with cystic fibrosis face a higher risk for infections, and many rely on antibiotics as part of their regular care. Over time, this can lead to infections that are resistant to antibiotics. The PASTEUR Act seeks to address the issue of antimicrobial resistance by creating a new post-approval payment model to incentivize the development of highly innovative antibiotics to fight deadly infections, bringing effective options into the hands of those patients who need them most.
|
|
|
Sincerely,
Mary Dwight
Senior Vice President, Chief Policy & Advocacy Officer
|
|
|
www.cff.org
4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US
|
|
|
Got this as a forward? Sign up to receive our future emails.
Opt out of this mailing list
Opt out of all CF Foundation emails
|
|
|
This email was sent to [email protected].
To continue receiving our emails, add us to your address book.
|
|
|
|